Expert Analysis

Clinical Complications in HIV-Infected Patients

Source: CCO Official Conference Coverage of the 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention

Clinical Complications in HIV-Infected Patients

Faculty:

Andrew Carr, MBBS, MD, FRACP
Donald P. Kotler, MD
Jürgen K. Rockstroh, MD

CREDIT INFORMATION

Release Date: 09/28/07

Expiration Date: 09/27/08

Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Registered Nurses: 1.3 Nursing contact hours

Pharmacists: 1.3 contact hours (0.13 CEUs)

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Describe data on the use of a genotype test to identify patients who are at increased risk of abacavir hypersensitivity reactions
Discuss data that indicate a sexual transmission route for hepatitis C virus
Summarize data about metabolic effects of antiretroviral therapy

Topics covered include:

HLA-B*5701 Screening for the Prevention of Abacavir Hypersensitivity
The Role of PIs vs Thymidine Analogue NRTIs in the Development of Metabolic Abnormalities
D:A:D Study: Diabetes as a Cardiac Risk Equivalent for Cardiovascular Disease
Predictors and Interventions for Cardiovascular Disease
Sexual Transmission of HCV in MSM in Europe
Lamivudine and Tenofovir for the Treatment of HBV in HIV/HBV-Coinfected Patients
SMART Trial: The Importance of Maintaining High CD4+ Cell Counts in HIV/HBV-Coinfected Patients
Noninvasive Liver Tests in Hepatitis
Tuberculosis and Antiretroviral Treatment

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.